Among COVID-19 patients with Asthma: Paxlovid recipients had lower Hospitalization Risk compared to Molnupiravir: Study Dr Riya Dave6 March 2025 8:15 PM ISTResearchers have found in a new study that among COVID-19 patients with asthma, those who received Paxlovid had a significantly lower risk of...
Early Oral Antivirals Reduce Risk of Post-COVID Condition, Study Finds Dr Riya Dave4 Jun 2024 9:00 PM ISTResearchers have found that the early use of oral antiviral drugs during the acute phase of COVID-19 significantly reduces the risk of developing...
Medical Bulletin 04/October/2023 Isra Zaman4 Oct 2023 3:00 PM ISTHere are the top medical news of the day:WHO Recommends new Malaria Vaccine for children which is cost-effective and efficientIn a significant...
Covid antiviral drug Molnupiravir linked to mutations in SARS CoV 2 genome Isra Zaman4 Oct 2023 9:15 AM ISTMolnupiravir, an antiviral medication widely employed against SARS-CoV-2, has shown the ability to induce mutations in the virus's genome during...
Medical Bulletin 2/October/2023 Isra Zaman2 Oct 2023 3:15 PM ISTHere are the top medical news of the day:FDA approves Depression drug after rejecting it multiple times in 20 years Gepirone hydrochloride...
Researchers find Ritomavir boosted Nirmatrelvir outperforms Molnupiravir in early COVID 19 treatment Isra Zaman2 Oct 2023 9:00 AM ISTIn an ongoing international study published in The Lancet Infectious Diseases , researchers have found that both molnupiravir and ritonavir-boosted...
Paxlovid and Molnupiravir Reduce Mortality and Hospitalisation in High-Risk Omicron-Infected Patients Dr Riya Dave23 Sept 2023 11:30 AM ISTRitonavir-boosted Nirmatrelvir and Molnupiravir, two oral antiviral drugs currently used to treat nonhospitalized COVID-19 patients at high risk of...
Merck, Ridgeback Biotherapeutics withdraw COVID pill Molnupiravir application in EU Ruchika Sharma30 Jun 2023 10:00 AM ISTMerck and Co and partner Ridgeback Biotherapeutics said on Tuesday they had withdrawn their COVID-19 pill application in the European Union,...
Merck beats first-quarter expectations on Keytruda, Gardasil strength Ruchika Sharma30 April 2023 4:00 PM ISTBengaluru: Drugmaker Merck & Co Inc on Thursday posted better-than-expected results for the first quarter on the strength of its blockbuster...
Do not use Molnupiravur, Favipiravir, Azithromycin, Doxycycline, Ivermectin etc in COVID-19: ICMR revised guidelines Dr. Nandita Mohan20 March 2023 5:10 PM ISTWith a sudden spurt in COVID-19 cases across various parts of the country, the Indian Council of Medical Research (ICMR), the leading body for medical...
Health Bulletin 20/March/2023 Dr. Nandita Mohan20 March 2023 4:14 PM ISTHere are the top health stories for the day:NCDRC holds no medical negligence, relief of Rs 17 lakh to orthopaedic surgeon, nursing homeThe National...
MAJOR UPDATE: Do Not Use Molnupiravur, Favipiravir, Azithromycin, Doxycycline, Ivermectin etc in COVID-19, says ICMR New Guideline Kajal Rajput20 March 2023 12:01 PM IST"Antibiotics should not be used unless there is clinical suspicion of bacterial infection. The possibility of coinfection of COVID-19 with other...
